|
KIAA0664P3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72899999872911E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04969999999527E-05 |
| Normal-vs-Stage2 |
3.42460000357647E-08 |
| Normal-vs-Stage3 |
8.74839978237674E-10 |
| Normal-vs-Stage4 |
5.59329999999525E-05 |
| Stage1-vs-Stage2 |
1.138010E-02 |
| Stage1-vs-Stage3 |
1.122270E-02 |
| Stage1-vs-Stage4 |
4.901400E-01 |
| Stage2-vs-Stage3 |
7.336800E-01 |
| Stage2-vs-Stage4 |
2.252800E-01 |
| Stage3-vs-Stage4 |
2.901400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.22480000042513E-07 |
| Normal-vs-AfricanAmerican |
1.438980E-03 |
| Normal-vs-Asian |
1.281940E-02 |
| Caucasian-vs-AfricanAmerican |
9.914200E-01 |
| Caucasian-vs-Asian |
1.551770E-01 |
| AfricanAmerican-vs-Asian |
3.401600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.50139999613941E-08 |
| Normal-vs-Female |
1.2549999994782E-07 |
| Male-vs-Female |
4.368800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.13079999989274E-07 |
| Normal-vs-Age(41-60Yrs) |
4.84690000002175E-06 |
| Normal-vs-Age(61-80Yrs) |
1.1659999965552E-08 |
| Normal-vs-Age(81-100Yrs) |
1.66008999999967E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.989000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.554300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.351620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.357600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.762000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.717200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.419600E-03 |
| Classical-VS-Follicular |
5.710100E-02 |
| Classical-VS-Other |
5.576800E-01 |
| Classical-VS-Normal |
5.25589999966769E-07 |
| Tall-VS-Follicular |
7.239200E-01 |
| Tall-VS-Other |
5.914000E-01 |
| Tall-VS-Normal |
7.99110000393455E-08 |
| Follicular-VS-Other |
8.569400E-01 |
| Follicular-VS-Normal |
3.71450000002937E-06 |
| Other-VS-Normal |
2.917700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40020000038987E-08 |
| Normal-vs-N1 |
2.063200E-03 |
| N0-vs-N1 |
1.730850E-01 |
|
|
